Ex-Shire CEO Flemming Ornskov emerges as Galderma CEO after $10B Nestlé spinout

8th October 2019 Uncategorised 0

As Takeda folds in Shire, two of the rare disease specialist’s former top leaders have found themselves a new home at Nestlé skin health spinoff Galderma. Flemming Ornskov, Shire’s most recent CEO who orchestrated the Baxalta buyout, will lead Galderma as CEO, and his former CFO will also tag along.

More: Ex-Shire CEO Flemming Ornskov emerges as Galderma CEO after B Nestlé spinout
Source: fierce